Emerson Electric Co. (EMR) Stock Competitors & Peer Comparison
See (EMR) competitors and their performances in Stock Market.
Peer Comparison Table: Industrial - Machinery Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EMR | $139.54 | +0.33% | 78.2B | 22.73 | $6.14 | +1.57% |
| PH | $953.21 | -0.54% | 120.2B | 31.01 | $30.73 | +0.78% |
| TT | $469.98 | -1.06% | 103.9B | 35.47 | $13.25 | +0.85% |
| CMI | $648.48 | +0.10% | 89.5B | 27.04 | $23.98 | +1.24% |
| ITW | $276.05 | +1.71% | 81.4B | 26.27 | $10.77 | +2.33% |
| PCAR | $126.20 | -0.37% | 66.4B | 26.85 | $4.70 | +2.18% |
| CARR | $68.69 | -0.94% | 57.1B | 27.48 | $2.50 | +1.35% |
| ROK | $461.85 | -1.46% | 51.4B | 37.82 | $12.21 | +1.19% |
| IR | $82.24 | +3.92% | 33.2B | 25.01 | $3.39 | +0.10% |
| XYL | $122.78 | -2.01% | 29.2B | 23.75 | $5.17 | +1.34% |
Stock Comparison
EMR vs PH Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, PH has a market cap of 120.2B. Regarding current trading prices, EMR is priced at $139.54, while PH trades at $953.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas PH's P/E ratio is 31.01. In terms of profitability, EMR's ROE is +0.12%, compared to PH's ROE of +0.25%. Regarding short-term risk, EMR is less volatile compared to PH. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PH's competition here
EMR vs TT Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, TT has a market cap of 103.9B. Regarding current trading prices, EMR is priced at $139.54, while TT trades at $469.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas TT's P/E ratio is 35.47. In terms of profitability, EMR's ROE is +0.12%, compared to TT's ROE of +0.35%. Regarding short-term risk, EMR is more volatile compared to TT. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check TT's competition here
EMR vs CMI Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, CMI has a market cap of 89.5B. Regarding current trading prices, EMR is priced at $139.54, while CMI trades at $648.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas CMI's P/E ratio is 27.04. In terms of profitability, EMR's ROE is +0.12%, compared to CMI's ROE of +0.22%. Regarding short-term risk, EMR is less volatile compared to CMI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CMI's competition here
EMR vs ITW Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, ITW has a market cap of 81.4B. Regarding current trading prices, EMR is priced at $139.54, while ITW trades at $276.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas ITW's P/E ratio is 26.27. In terms of profitability, EMR's ROE is +0.12%, compared to ITW's ROE of +0.97%. Regarding short-term risk, EMR is less volatile compared to ITW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check ITW's competition here
EMR vs PCAR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, PCAR has a market cap of 66.4B. Regarding current trading prices, EMR is priced at $139.54, while PCAR trades at $126.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas PCAR's P/E ratio is 26.85. In terms of profitability, EMR's ROE is +0.12%, compared to PCAR's ROE of +0.13%. Regarding short-term risk, EMR is more volatile compared to PCAR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check PCAR's competition here
EMR vs CARR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, CARR has a market cap of 57.1B. Regarding current trading prices, EMR is priced at $139.54, while CARR trades at $68.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas CARR's P/E ratio is 27.48. In terms of profitability, EMR's ROE is +0.12%, compared to CARR's ROE of +0.09%. Regarding short-term risk, EMR is more volatile compared to CARR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check CARR's competition here
EMR vs ROK Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, ROK has a market cap of 51.4B. Regarding current trading prices, EMR is priced at $139.54, while ROK trades at $461.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas ROK's P/E ratio is 37.82. In terms of profitability, EMR's ROE is +0.12%, compared to ROK's ROE of +0.30%. Regarding short-term risk, EMR is more volatile compared to ROK. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check ROK's competition here
EMR vs IR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, IR has a market cap of 33.2B. Regarding current trading prices, EMR is priced at $139.54, while IR trades at $82.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas IR's P/E ratio is 25.01. In terms of profitability, EMR's ROE is +0.12%, compared to IR's ROE of +0.06%. Regarding short-term risk, EMR is less volatile compared to IR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check IR's competition here
EMR vs XYL Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, XYL has a market cap of 29.2B. Regarding current trading prices, EMR is priced at $139.54, while XYL trades at $122.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas XYL's P/E ratio is 23.75. In terms of profitability, EMR's ROE is +0.12%, compared to XYL's ROE of +0.09%. Regarding short-term risk, EMR is more volatile compared to XYL. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check XYL's competition here
EMR vs DOV Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, DOV has a market cap of 28.8B. Regarding current trading prices, EMR is priced at $139.54, while DOV trades at $214.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas DOV's P/E ratio is 21.74. In terms of profitability, EMR's ROE is +0.12%, compared to DOV's ROE of +0.15%. Regarding short-term risk, EMR is more volatile compared to DOV. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check DOV's competition here
EMR vs OTIS Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, OTIS has a market cap of 28.2B. Regarding current trading prices, EMR is priced at $139.54, while OTIS trades at $73.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas OTIS's P/E ratio is 18.27. In terms of profitability, EMR's ROE is +0.12%, compared to OTIS's ROE of -0.27%. Regarding short-term risk, EMR is less volatile compared to OTIS. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check OTIS's competition here
EMR vs SYM Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, SYM has a market cap of 26.5B. Regarding current trading prices, EMR is priced at $139.54, while SYM trades at $41.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas SYM's P/E ratio is 59.77. In terms of profitability, EMR's ROE is +0.12%, compared to SYM's ROE of -0.01%. Regarding short-term risk, EMR is less volatile compared to SYM. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SYM's competition here
EMR vs P Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, P has a market cap of 23.1B. Regarding current trading prices, EMR is priced at $139.54, while P trades at $69.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas P's P/E ratio is 31.97. In terms of profitability, EMR's ROE is +0.12%, compared to P's ROE of +0.16%. Regarding short-term risk, EMR is less volatile compared to P. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check P's competition here
EMR vs INIO Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, INIO has a market cap of 21B. Regarding current trading prices, EMR is priced at $139.54, while INIO trades at $27.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas INIO's P/E ratio is -1401.00. In terms of profitability, EMR's ROE is +0.12%, compared to INIO's ROE of +0.12%. Regarding short-term risk, EMR is less volatile compared to INIO. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check INIO's competition here
EMR vs ITT Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, ITT has a market cap of 17.5B. Regarding current trading prices, EMR is priced at $139.54, while ITT trades at $192.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas ITT's P/E ratio is 26.96. In terms of profitability, EMR's ROE is +0.12%, compared to ITT's ROE of +0.13%. Regarding short-term risk, EMR is more volatile compared to ITT. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check ITT's competition here
EMR vs MAIR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, MAIR has a market cap of 17B. Regarding current trading prices, EMR is priced at $139.54, while MAIR trades at $34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas MAIR's P/E ratio is 188.83. In terms of profitability, EMR's ROE is +0.12%, compared to MAIR's ROE of -0.83%. Regarding short-term risk, EMR is less volatile compared to MAIR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MAIR's competition here
EMR vs IEX Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, IEX has a market cap of 16.7B. Regarding current trading prices, EMR is priced at $139.54, while IEX trades at $224.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas IEX's P/E ratio is 27.44. In terms of profitability, EMR's ROE is +0.12%, compared to IEX's ROE of +0.13%. Regarding short-term risk, EMR is more volatile compared to IEX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check IEX's competition here
EMR vs NDSN Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, NDSN has a market cap of 16.1B. Regarding current trading prices, EMR is priced at $139.54, while NDSN trades at $288.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas NDSN's P/E ratio is 26.29. In terms of profitability, EMR's ROE is +0.12%, compared to NDSN's ROE of +0.17%. Regarding short-term risk, EMR is more volatile compared to NDSN. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check NDSN's competition here
EMR vs RRX Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, RRX has a market cap of 13.8B. Regarding current trading prices, EMR is priced at $139.54, while RRX trades at $206.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas RRX's P/E ratio is 21.39. In terms of profitability, EMR's ROE is +0.12%, compared to RRX's ROE of +0.04%. Regarding short-term risk, EMR is less volatile compared to RRX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check RRX's competition here
EMR vs GNRC Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, GNRC has a market cap of 12.6B. Regarding current trading prices, EMR is priced at $139.54, while GNRC trades at $214.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas GNRC's P/E ratio is 31.18. In terms of profitability, EMR's ROE is +0.12%, compared to GNRC's ROE of +0.07%. Regarding short-term risk, EMR is less volatile compared to GNRC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GNRC's competition here
EMR vs CR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, CR has a market cap of 12.6B. Regarding current trading prices, EMR is priced at $139.54, while CR trades at $217.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas CR's P/E ratio is 34.48. In terms of profitability, EMR's ROE is +0.12%, compared to CR's ROE of +0.16%. Regarding short-term risk, EMR is more volatile compared to CR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check CR's competition here
EMR vs GGG Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, GGG has a market cap of 12.4B. Regarding current trading prices, EMR is priced at $139.54, while GGG trades at $74.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas GGG's P/E ratio is 25.63. In terms of profitability, EMR's ROE is +0.12%, compared to GGG's ROE of +0.20%. Regarding short-term risk, EMR is more volatile compared to GGG. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check GGG's competition here
EMR vs WTS Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, WTS has a market cap of 11.6B. Regarding current trading prices, EMR is priced at $139.54, while WTS trades at $346.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas WTS's P/E ratio is 30.81. In terms of profitability, EMR's ROE is +0.12%, compared to WTS's ROE of +0.18%. Regarding short-term risk, EMR is more volatile compared to WTS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check WTS's competition here
EMR vs DCI Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, DCI has a market cap of 10.5B. Regarding current trading prices, EMR is priced at $139.54, while DCI trades at $90.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas DCI's P/E ratio is 23.41. In terms of profitability, EMR's ROE is +0.12%, compared to DCI's ROE of +0.28%. Regarding short-term risk, EMR is more volatile compared to DCI. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check DCI's competition here
EMR vs PNR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, PNR has a market cap of 10.1B. Regarding current trading prices, EMR is priced at $139.54, while PNR trades at $62.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas PNR's P/E ratio is 12.41. In terms of profitability, EMR's ROE is +0.12%, compared to PNR's ROE of +0.18%. Regarding short-term risk, EMR is less volatile compared to PNR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PNR's competition here
EMR vs GTLS Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, GTLS has a market cap of 10B. Regarding current trading prices, EMR is priced at $139.54, while GTLS trades at $209.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas GTLS's P/E ratio is 25.47. In terms of profitability, EMR's ROE is +0.12%, compared to GTLS's ROE of -0.01%. Regarding short-term risk, EMR is more volatile compared to GTLS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check GTLS's competition here
EMR vs FLS Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, FLS has a market cap of 8.7B. Regarding current trading prices, EMR is priced at $139.54, while FLS trades at $68.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas FLS's P/E ratio is 18.16. In terms of profitability, EMR's ROE is +0.12%, compared to FLS's ROE of +0.16%. Regarding short-term risk, EMR is more volatile compared to FLS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check FLS's competition here
EMR vs AOS Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, AOS has a market cap of 8.2B. Regarding current trading prices, EMR is priced at $139.54, while AOS trades at $58.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas AOS's P/E ratio is 15.65. In terms of profitability, EMR's ROE is +0.12%, compared to AOS's ROE of +0.28%. Regarding short-term risk, EMR is less volatile compared to AOS. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check AOS's competition here
EMR vs OKLO Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, OKLO has a market cap of 7.2B. Regarding current trading prices, EMR is priced at $139.54, while OKLO trades at $41.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas OKLO's P/E ratio is -48.93. In terms of profitability, EMR's ROE is +0.12%, compared to OKLO's ROE of -0.09%. Regarding short-term risk, EMR is less volatile compared to OKLO. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check OKLO's competition here
EMR vs MIDDV Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, MIDDV has a market cap of 7B. Regarding current trading prices, EMR is priced at $139.54, while MIDDV trades at $139.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas MIDDV's P/E ratio is 64.59. In terms of profitability, EMR's ROE is +0.12%, compared to MIDDV's ROE of N/A. Regarding short-term risk, EMR is more volatile compared to MIDDV. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check MIDDV's competition here
EMR vs JBTM Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, JBTM has a market cap of 7B. Regarding current trading prices, EMR is priced at $139.54, while JBTM trades at $134.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas JBTM's P/E ratio is 19.18. In terms of profitability, EMR's ROE is +0.12%, compared to JBTM's ROE of +0.04%. Regarding short-term risk, EMR is less volatile compared to JBTM. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check JBTM's competition here
EMR vs NPO Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, NPO has a market cap of 6.8B. Regarding current trading prices, EMR is priced at $139.54, while NPO trades at $322.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas NPO's P/E ratio is 39.63. In terms of profitability, EMR's ROE is +0.12%, compared to NPO's ROE of +0.03%. Regarding short-term risk, EMR is less volatile compared to NPO. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check NPO's competition here
EMR vs GTES Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, GTES has a market cap of 6.8B. Regarding current trading prices, EMR is priced at $139.54, while GTES trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas GTES's P/E ratio is 17.61. In terms of profitability, EMR's ROE is +0.12%, compared to GTES's ROE of +0.07%. Regarding short-term risk, EMR is less volatile compared to GTES. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GTES's competition here
EMR vs AEBIV Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, AEBIV has a market cap of 6.5B. Regarding current trading prices, EMR is priced at $139.54, while AEBIV trades at $83.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas AEBIV's P/E ratio is 213.49. In terms of profitability, EMR's ROE is +0.12%, compared to AEBIV's ROE of +0.00%. Regarding short-term risk, EMR is more volatile compared to AEBIV. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check AEBIV's competition here
EMR vs MIDD Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, MIDD has a market cap of 6B. Regarding current trading prices, EMR is priced at $139.54, while MIDD trades at $133.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas MIDD's P/E ratio is 15.00. In terms of profitability, EMR's ROE is +0.12%, compared to MIDD's ROE of -0.14%. Regarding short-term risk, EMR is less volatile compared to MIDD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MIDD's competition here
EMR vs XMTR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, XMTR has a market cap of 5.3B. Regarding current trading prices, EMR is priced at $139.54, while XMTR trades at $98.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas XMTR's P/E ratio is 205.29. In terms of profitability, EMR's ROE is +0.12%, compared to XMTR's ROE of -0.19%. Regarding short-term risk, EMR is less volatile compared to XMTR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check XMTR's competition here
EMR vs CSWI Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, CSWI has a market cap of 4.9B. Regarding current trading prices, EMR is priced at $139.54, while CSWI trades at $305.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas CSWI's P/E ratio is 36.36. In terms of profitability, EMR's ROE is +0.12%, compared to CSWI's ROE of +0.10%. Regarding short-term risk, EMR is more volatile compared to CSWI. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check CSWI's competition here
EMR vs FELE Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, FELE has a market cap of 4.7B. Regarding current trading prices, EMR is priced at $139.54, while FELE trades at $105.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas FELE's P/E ratio is 24.52. In terms of profitability, EMR's ROE is +0.12%, compared to FELE's ROE of +0.11%. Regarding short-term risk, EMR is more volatile compared to FELE. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check FELE's competition here
EMR vs CSW Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, CSW has a market cap of 4.6B. Regarding current trading prices, EMR is priced at $139.54, while CSW trades at $279.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas CSW's P/E ratio is 26.92. In terms of profitability, EMR's ROE is +0.12%, compared to CSW's ROE of +0.10%. Regarding short-term risk, EMR is less volatile compared to CSW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CSW's competition here
EMR vs BMI Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, BMI has a market cap of 4.4B. Regarding current trading prices, EMR is priced at $139.54, while BMI trades at $149.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas BMI's P/E ratio is 34.07. In terms of profitability, EMR's ROE is +0.12%, compared to BMI's ROE of +0.19%. Regarding short-term risk, EMR is less volatile compared to BMI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BMI's competition here
EMR vs AIMC Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, AIMC has a market cap of 4.1B. Regarding current trading prices, EMR is priced at $139.54, while AIMC trades at $61.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas AIMC's P/E ratio is 31.95. In terms of profitability, EMR's ROE is +0.12%, compared to AIMC's ROE of +0.06%. Regarding short-term risk, EMR is more volatile compared to AIMC. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check AIMC's competition here
EMR vs JBT Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, JBT has a market cap of 4B. Regarding current trading prices, EMR is priced at $139.54, while JBT trades at $125.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas JBT's P/E ratio is 28.04. In terms of profitability, EMR's ROE is +0.12%, compared to JBT's ROE of +0.04%. Regarding short-term risk, EMR is more volatile compared to JBT. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check JBT's competition here
EMR vs MWA Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, MWA has a market cap of 4B. Regarding current trading prices, EMR is priced at $139.54, while MWA trades at $25.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas MWA's P/E ratio is 18.06. In terms of profitability, EMR's ROE is +0.12%, compared to MWA's ROE of +0.21%. Regarding short-term risk, EMR is more volatile compared to MWA. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check MWA's competition here
EMR vs MIR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, MIR has a market cap of 3.9B. Regarding current trading prices, EMR is priced at $139.54, while MIR trades at $15.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas MIR's P/E ratio is 33.26. In terms of profitability, EMR's ROE is +0.12%, compared to MIR's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to MIR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MIR's competition here
EMR vs SXI Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, SXI has a market cap of 3.7B. Regarding current trading prices, EMR is priced at $139.54, while SXI trades at $302.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas SXI's P/E ratio is 35.39. In terms of profitability, EMR's ROE is +0.12%, compared to SXI's ROE of +0.14%. Regarding short-term risk, EMR is less volatile compared to SXI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SXI's competition here
EMR vs KAI Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, KAI has a market cap of 3.7B. Regarding current trading prices, EMR is priced at $139.54, while KAI trades at $311.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas KAI's P/E ratio is 31.02. In terms of profitability, EMR's ROE is +0.12%, compared to KAI's ROE of +0.11%. Regarding short-term risk, EMR is less volatile compared to KAI. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check KAI's competition here
EMR vs GTLS-PB Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, GTLS-PB has a market cap of 3.2B. Regarding current trading prices, EMR is priced at $139.54, while GTLS-PB trades at $72.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas GTLS-PB's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to GTLS-PB's ROE of -0.01%. Regarding short-term risk, EMR is more volatile compared to GTLS-PB. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check GTLS-PB's competition here
EMR vs CXT Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, CXT has a market cap of 2.9B. Regarding current trading prices, EMR is priced at $139.54, while CXT trades at $51.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas CXT's P/E ratio is 12.44. In terms of profitability, EMR's ROE is +0.12%, compared to CXT's ROE of +0.11%. Regarding short-term risk, EMR is less volatile compared to CXT. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CXT's competition here
EMR vs ATS Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, ATS has a market cap of 2.7B. Regarding current trading prices, EMR is priced at $139.54, while ATS trades at $27.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas ATS's P/E ratio is 22.40. In terms of profitability, EMR's ROE is +0.12%, compared to ATS's ROE of +0.04%. Regarding short-term risk, EMR is more volatile compared to ATS. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check ATS's competition here
EMR vs HLIO Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, HLIO has a market cap of 2.7B. Regarding current trading prices, EMR is priced at $139.54, while HLIO trades at $81.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas HLIO's P/E ratio is 27.79. In terms of profitability, EMR's ROE is +0.12%, compared to HLIO's ROE of +0.07%. Regarding short-term risk, EMR is less volatile compared to HLIO. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HLIO's competition here
EMR vs MIR-WT Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, MIR-WT has a market cap of 2.4B. Regarding current trading prices, EMR is priced at $139.54, while MIR-WT trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas MIR-WT's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to MIR-WT's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to MIR-WT. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MIR-WT's competition here
EMR vs HI Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, HI has a market cap of 2.3B. Regarding current trading prices, EMR is priced at $139.54, while HI trades at $31.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas HI's P/E ratio is 65.27. In terms of profitability, EMR's ROE is +0.12%, compared to HI's ROE of +0.03%. Regarding short-term risk, EMR is more volatile compared to HI. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check HI's competition here
EMR vs CFX Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, CFX has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $139.54, while CFX trades at $39.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas CFX's P/E ratio is 28.55. In terms of profitability, EMR's ROE is +0.12%, compared to CFX's ROE of -0.60%. Regarding short-term risk, EMR is less volatile compared to CFX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CFX's competition here
EMR vs GRC Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, GRC has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $139.54, while GRC trades at $79.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas GRC's P/E ratio is 33.92. In terms of profitability, EMR's ROE is +0.12%, compared to GRC's ROE of +0.14%. Regarding short-term risk, EMR is less volatile compared to GRC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GRC's competition here
EMR vs SHPW Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, SHPW has a market cap of 2.1B. Regarding current trading prices, EMR is priced at $139.54, while SHPW trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas SHPW's P/E ratio is -0.05. In terms of profitability, EMR's ROE is +0.12%, compared to SHPW's ROE of -0.93%. Regarding short-term risk, EMR is more volatile compared to SHPW. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check SHPW's competition here
EMR vs EPAC Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, EPAC has a market cap of 1.8B. Regarding current trading prices, EMR is priced at $139.54, while EPAC trades at $34.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas EPAC's P/E ratio is 18.50. In terms of profitability, EMR's ROE is +0.12%, compared to EPAC's ROE of +0.22%. Regarding short-term risk, EMR is more volatile compared to EPAC. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check EPAC's competition here
EMR vs BW-PA Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, BW-PA has a market cap of 1.7B. Regarding current trading prices, EMR is priced at $139.54, while BW-PA trades at $22.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas BW-PA's P/E ratio is -23.90. In terms of profitability, EMR's ROE is +0.12%, compared to BW-PA's ROE of +0.61%. Regarding short-term risk, EMR is less volatile compared to BW-PA. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BW-PA's competition here
EMR vs CYD Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, CYD has a market cap of 1.6B. Regarding current trading prices, EMR is priced at $139.54, while CYD trades at $43.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas CYD's P/E ratio is 32.97. In terms of profitability, EMR's ROE is +0.12%, compared to CYD's ROE of +0.04%. Regarding short-term risk, EMR is less volatile compared to CYD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CYD's competition here
EMR vs AMSC Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, AMSC has a market cap of 1.6B. Regarding current trading prices, EMR is priced at $139.54, while AMSC trades at $33.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas AMSC's P/E ratio is 9.33. In terms of profitability, EMR's ROE is +0.12%, compared to AMSC's ROE of +0.30%. Regarding short-term risk, EMR is less volatile compared to AMSC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check AMSC's competition here
EMR vs MFPVV Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, MFPVV has a market cap of 1.6B. Regarding current trading prices, EMR is priced at $139.54, while MFPVV trades at $35.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas MFPVV's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to MFPVV's ROE of N/A. Regarding short-term risk, EMR is more volatile compared to MFPVV. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check MFPVV's competition here
EMR vs TNC Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, TNC has a market cap of 1.5B. Regarding current trading prices, EMR is priced at $139.54, while TNC trades at $86.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas TNC's P/E ratio is 17.56. In terms of profitability, EMR's ROE is +0.12%, compared to TNC's ROE of +0.05%. Regarding short-term risk, EMR is more volatile compared to TNC. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check TNC's competition here
EMR vs GHM Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, GHM has a market cap of 1.3B. Regarding current trading prices, EMR is priced at $139.54, while GHM trades at $107.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas GHM's P/E ratio is 86.50. In terms of profitability, EMR's ROE is +0.12%, compared to GHM's ROE of +0.10%. Regarding short-term risk, EMR is less volatile compared to GHM. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GHM's competition here
EMR vs CIR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, CIR has a market cap of 1.1B. Regarding current trading prices, EMR is priced at $139.54, while CIR trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas CIR's P/E ratio is 38.89. In terms of profitability, EMR's ROE is +0.12%, compared to CIR's ROE of +0.13%. Regarding short-term risk, EMR is more volatile compared to CIR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check CIR's competition here
EMR vs BW Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, BW has a market cap of 1.1B. Regarding current trading prices, EMR is priced at $139.54, while BW trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas BW's P/E ratio is -12.20. In terms of profitability, EMR's ROE is +0.12%, compared to BW's ROE of +0.61%. Regarding short-term risk, EMR is less volatile compared to BW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BW's competition here
EMR vs KODK Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, KODK has a market cap of 750.9M. Regarding current trading prices, EMR is priced at $139.54, while KODK trades at $7.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas KODK's P/E ratio is -4.21. In terms of profitability, EMR's ROE is +0.12%, compared to KODK's ROE of -0.18%. Regarding short-term risk, EMR is more volatile compared to KODK. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check KODK's competition here
EMR vs PSIX Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, PSIX has a market cap of 697.3M. Regarding current trading prices, EMR is priced at $139.54, while PSIX trades at $30.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas PSIX's P/E ratio is 6.71. In terms of profitability, EMR's ROE is +0.12%, compared to PSIX's ROE of +0.62%. Regarding short-term risk, EMR is less volatile compared to PSIX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PSIX's competition here
EMR vs KRNT Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, KRNT has a market cap of 696.3M. Regarding current trading prices, EMR is priced at $139.54, while KRNT trades at $15.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas KRNT's P/E ratio is 51.81. In terms of profitability, EMR's ROE is +0.12%, compared to KRNT's ROE of -0.02%. Regarding short-term risk, EMR is more volatile compared to KRNT. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check KRNT's competition here
EMR vs PKOH Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, PKOH has a market cap of 543.7M. Regarding current trading prices, EMR is priced at $139.54, while PKOH trades at $37.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas PKOH's P/E ratio is 13.99. In terms of profitability, EMR's ROE is +0.12%, compared to PKOH's ROE of +0.06%. Regarding short-term risk, EMR is less volatile compared to PKOH. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PKOH's competition here
EMR vs EROC Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, EROC has a market cap of 518.8M. Regarding current trading prices, EMR is priced at $139.54, while EROC trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas EROC's P/E ratio is -359.00. In terms of profitability, EMR's ROE is +0.12%, compared to EROC's ROE of +0.41%. Regarding short-term risk, EMR is less volatile compared to EROC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check EROC's competition here
EMR vs MTW Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, MTW has a market cap of 467.9M. Regarding current trading prices, EMR is priced at $139.54, while MTW trades at $13.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas MTW's P/E ratio is 37.23. In terms of profitability, EMR's ROE is +0.12%, compared to MTW's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to MTW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MTW's competition here
EMR vs LXFR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, LXFR has a market cap of 445.9M. Regarding current trading prices, EMR is priced at $139.54, while LXFR trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas LXFR's P/E ratio is 14.36. In terms of profitability, EMR's ROE is +0.12%, compared to LXFR's ROE of +0.03%. Regarding short-term risk, EMR is more volatile compared to LXFR. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check LXFR's competition here
EMR vs BGRY Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, BGRY has a market cap of 340.7M. Regarding current trading prices, EMR is priced at $139.54, while BGRY trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas BGRY's P/E ratio is -2.86. In terms of profitability, EMR's ROE is +0.12%, compared to BGRY's ROE of -0.96%. Regarding short-term risk, EMR is more volatile compared to BGRY. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check BGRY's competition here
EMR vs SERV Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, SERV has a market cap of 339M. Regarding current trading prices, EMR is priced at $139.54, while SERV trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas SERV's P/E ratio is -2.53. In terms of profitability, EMR's ROE is +0.12%, compared to SERV's ROE of -0.47%. Regarding short-term risk, EMR is less volatile compared to SERV. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SERV's competition here
EMR vs TWIN Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, TWIN has a market cap of 325.8M. Regarding current trading prices, EMR is priced at $139.54, while TWIN trades at $22.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas TWIN's P/E ratio is 68.45. In terms of profitability, EMR's ROE is +0.12%, compared to TWIN's ROE of +0.15%. Regarding short-term risk, EMR is more volatile compared to TWIN. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check TWIN's competition here
EMR vs XE Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, XE has a market cap of 307.7M. Regarding current trading prices, EMR is priced at $139.54, while XE trades at $14.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas XE's P/E ratio is -42.18. In terms of profitability, EMR's ROE is +0.12%, compared to XE's ROE of -0.93%. Regarding short-term risk, EMR is less volatile compared to XE. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check XE's competition here
EMR vs OFLX Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, OFLX has a market cap of 301.6M. Regarding current trading prices, EMR is priced at $139.54, while OFLX trades at $29.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas OFLX's P/E ratio is 22.47. In terms of profitability, EMR's ROE is +0.12%, compared to OFLX's ROE of +0.16%. Regarding short-term risk, EMR is less volatile compared to OFLX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check OFLX's competition here
EMR vs RR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, RR has a market cap of 293.9M. Regarding current trading prices, EMR is priced at $139.54, while RR trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas RR's P/E ratio is -11.55. In terms of profitability, EMR's ROE is +0.12%, compared to RR's ROE of -0.11%. Regarding short-term risk, EMR is less volatile compared to RR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check RR's competition here
EMR vs GENC Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, GENC has a market cap of 235.4M. Regarding current trading prices, EMR is priced at $139.54, while GENC trades at $16.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas GENC's P/E ratio is 15.59. In terms of profitability, EMR's ROE is +0.12%, compared to GENC's ROE of +0.07%. Regarding short-term risk, EMR is less volatile compared to GENC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GENC's competition here
EMR vs VELO Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, VELO has a market cap of 205.4M. Regarding current trading prices, EMR is priced at $139.54, while VELO trades at $10.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas VELO's P/E ratio is -8.27. In terms of profitability, EMR's ROE is +0.12%, compared to VELO's ROE of -1.50%. Regarding short-term risk, EMR is less volatile compared to VELO. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check VELO's competition here
EMR vs TAYD Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, TAYD has a market cap of 176M. Regarding current trading prices, EMR is priced at $139.54, while TAYD trades at $54.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas TAYD's P/E ratio is 16.57. In terms of profitability, EMR's ROE is +0.12%, compared to TAYD's ROE of +0.16%. Regarding short-term risk, EMR is less volatile compared to TAYD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check TAYD's competition here
EMR vs SHMDW Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, SHMDW has a market cap of 162.7M. Regarding current trading prices, EMR is priced at $139.54, while SHMDW trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas SHMDW's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to SHMDW's ROE of +0.74%. Regarding short-term risk, EMR is less volatile compared to SHMDW. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SHMDW's competition here
EMR vs SHMD Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, SHMD has a market cap of 161.7M. Regarding current trading prices, EMR is priced at $139.54, while SHMD trades at $4.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas SHMD's P/E ratio is -2.27. In terms of profitability, EMR's ROE is +0.12%, compared to SHMD's ROE of +0.74%. Regarding short-term risk, EMR is less volatile compared to SHMD. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SHMD's competition here
EMR vs HURC Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, HURC has a market cap of 148.2M. Regarding current trading prices, EMR is priced at $139.54, while HURC trades at $21.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas HURC's P/E ratio is -11.67. In terms of profitability, EMR's ROE is +0.12%, compared to HURC's ROE of -0.06%. Regarding short-term risk, EMR is less volatile compared to HURC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HURC's competition here
EMR vs NPWR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, NPWR has a market cap of 137.4M. Regarding current trading prices, EMR is priced at $139.54, while NPWR trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas NPWR's P/E ratio is 0.30. In terms of profitability, EMR's ROE is +0.12%, compared to NPWR's ROE of -1.60%. Regarding short-term risk, EMR is less volatile compared to NPWR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check NPWR's competition here
EMR vs KULR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, KULR has a market cap of 121.7M. Regarding current trading prices, EMR is priced at $139.54, while KULR trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas KULR's P/E ratio is -2.01. In terms of profitability, EMR's ROE is +0.12%, compared to KULR's ROE of -0.57%. Regarding short-term risk, EMR is less volatile compared to KULR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check KULR's competition here
EMR vs HUHU Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, HUHU has a market cap of 114.7M. Regarding current trading prices, EMR is priced at $139.54, while HUHU trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas HUHU's P/E ratio is -89.64. In terms of profitability, EMR's ROE is +0.12%, compared to HUHU's ROE of -0.34%. Regarding short-term risk, EMR is less volatile compared to HUHU. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HUHU's competition here
EMR vs BWEN Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, BWEN has a market cap of 112.8M. Regarding current trading prices, EMR is priced at $139.54, while BWEN trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas BWEN's P/E ratio is -80.33. In terms of profitability, EMR's ROE is +0.12%, compared to BWEN's ROE of +0.08%. Regarding short-term risk, EMR is less volatile compared to BWEN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BWEN's competition here
EMR vs SOTK Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, SOTK has a market cap of 86.4M. Regarding current trading prices, EMR is priced at $139.54, while SOTK trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas SOTK's P/E ratio is 42.31. In terms of profitability, EMR's ROE is +0.12%, compared to SOTK's ROE of +0.11%. Regarding short-term risk, EMR is less volatile compared to SOTK. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SOTK's competition here
EMR vs PYR Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, PYR has a market cap of 68M. Regarding current trading prices, EMR is priced at $139.54, while PYR trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas PYR's P/E ratio is -3.17. In terms of profitability, EMR's ROE is +0.12%, compared to PYR's ROE of -1.12%. Regarding short-term risk, EMR is less volatile compared to PYR. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check PYR's competition here
EMR vs HDRN Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, HDRN has a market cap of 66.7M. Regarding current trading prices, EMR is priced at $139.54, while HDRN trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas HDRN's P/E ratio is N/A. In terms of profitability, EMR's ROE is +0.12%, compared to HDRN's ROE of +0.01%. Regarding short-term risk, EMR is less volatile compared to HDRN. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check HDRN's competition here
EMR vs CVV Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, CVV has a market cap of 49.4M. Regarding current trading prices, EMR is priced at $139.54, while CVV trades at $7.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas CVV's P/E ratio is -14.24. In terms of profitability, EMR's ROE is +0.12%, compared to CVV's ROE of -0.15%. Regarding short-term risk, EMR is less volatile compared to CVV. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check CVV's competition here
EMR vs MCRP Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, MCRP has a market cap of 39.4M. Regarding current trading prices, EMR is priced at $139.54, while MCRP trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas MCRP's P/E ratio is -5.40. In terms of profitability, EMR's ROE is +0.12%, compared to MCRP's ROE of +1.09%. Regarding short-term risk, EMR is less volatile compared to MCRP. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check MCRP's competition here
EMR vs XCH Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, XCH has a market cap of 36.2M. Regarding current trading prices, EMR is priced at $139.54, while XCH trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas XCH's P/E ratio is -1.67. In terms of profitability, EMR's ROE is +0.12%, compared to XCH's ROE of -1.37%. Regarding short-term risk, EMR is less volatile compared to XCH. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check XCH's competition here
EMR vs SCAG Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, SCAG has a market cap of 22.1M. Regarding current trading prices, EMR is priced at $139.54, while SCAG trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas SCAG's P/E ratio is -1.69. In terms of profitability, EMR's ROE is +0.12%, compared to SCAG's ROE of +0.02%. Regarding short-term risk, EMR is less volatile compared to SCAG. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check SCAG's competition here
EMR vs LASE Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, LASE has a market cap of 15.9M. Regarding current trading prices, EMR is priced at $139.54, while LASE trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas LASE's P/E ratio is -0.51. In terms of profitability, EMR's ROE is +0.12%, compared to LASE's ROE of -44.07%. Regarding short-term risk, EMR is less volatile compared to LASE. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check LASE's competition here
EMR vs GTEC Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, GTEC has a market cap of 15.2M. Regarding current trading prices, EMR is priced at $139.54, while GTEC trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas GTEC's P/E ratio is 2.29. In terms of profitability, EMR's ROE is +0.12%, compared to GTEC's ROE of +0.08%. Regarding short-term risk, EMR is less volatile compared to GTEC. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check GTEC's competition here
EMR vs BURU Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, BURU has a market cap of 8.9M. Regarding current trading prices, EMR is priced at $139.54, while BURU trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas BURU's P/E ratio is -0.04. In terms of profitability, EMR's ROE is +0.12%, compared to BURU's ROE of +2.27%. Regarding short-term risk, EMR is less volatile compared to BURU. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.Check BURU's competition here
EMR vs HCAI Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, HCAI has a market cap of 7.8M. Regarding current trading prices, EMR is priced at $139.54, while HCAI trades at $6.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas HCAI's P/E ratio is -0.01. In terms of profitability, EMR's ROE is +0.12%, compared to HCAI's ROE of -4.13%. Regarding short-term risk, EMR is more volatile compared to HCAI. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check HCAI's competition here
EMR vs JCSE Comparison July 2026
EMR plays a significant role within the Industrials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR stands at 78.2B. In comparison, JCSE has a market cap of 7M. Regarding current trading prices, EMR is priced at $139.54, while JCSE trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR currently has a P/E ratio of 22.73, whereas JCSE's P/E ratio is 2.09. In terms of profitability, EMR's ROE is +0.12%, compared to JCSE's ROE of +0.18%. Regarding short-term risk, EMR is more volatile compared to JCSE. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.Check JCSE's competition here